SVRASavara Inc.

CSNasdaq (XNAS)·USD

Identity

Security key: 22225
Ticker: SVRA
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 1996-11-18
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: SVRA

Detail

Enriched 2026-08-14 20:47

Market cap: $1,171,122,085.5
Shares outstanding (class): 204,927,212
Shares outstanding (weighted): 205,460,015
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 70
Location: AUSTIN, TX
Homepage: https://www.savarapharma.com
Description: Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Market cap and share counts drift.

Funds holding this security

61 funds · 61 positions · $104.72M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$33.16M	0.00%	6,072,561 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$19.52M	0.03%	3,574,800 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$19.41M	0.26%	3,554,970 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$8.25M	0.01%	1,511,251 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$6.53M	0.05%	1,196,093 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$4.23M	0.05%	775,563 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$2.02M	0.17%	369,253 NS	FIGI
VOYA SMALL COMPANY PORTFOLIO Voya VARIABLE PORTFOLIOS INC	—	$1.43M	0.79%	262,008 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.28M	0.03%	235,337 NS	FIGI
iShares Core S&P Total U.S. Stock Market ETF iShares Trust	ITOT	$903.3K	0.00%	165,439 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$834.1K	0.02%	152,758 NS	FIGI
VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS	—	$616.9K	0.00%	112,991 NS	FIGI
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$608.2K	0.05%	111,383 NS	FIGI
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$495.2K	0.03%	90,700 NS	FIGI
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX… VANGUARD INSTITUTIONAL INDEX FUNDS	—	$470.2K	0.00%	86,122 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERSVRA
FIGI_COMPOSITEBBG000MS0823
FIGI_SHARE_CLASSBBG001SFTVM9
CIK0001160308
ISINUS8051111016
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Savara Inc. is a pharmaceutical company developing therapies for rare respiratory diseases, matching the SIC code for pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.